Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

Background Recent years have witnessed a growing body of observational literature on the association between glucose-lowering treatments and cardiovascular disease. However, many of the studies are based on designs or analyses that inadequately address the methodological challenges involved.